RC RANDOM CHAOS

GLP-1 Drug May Slow Biological Aging in HIV Patients

· via Hacker News

Original source

GLP-1 may slow biological aging

Hacker News →

Semaglutide, a GLP-1 drug widely used for weight loss, appears to slow the buildup of biological aging markers in people with HIV, according to a randomized controlled trial published in Nature Communications. The 32-week study tracked 108 HIV patients using epigenetic clocks—molecular measurements that detect chemical tags on DNA controlling gene activity. Those receiving weekly semaglutide injections showed a 9% reduction in biological aging pace compared to placebo and slowed the progression of processes tied to mortality risk and age-related diseases.

The drug seems to work by reducing inflammation and visceral fat that accumulate in HIV patients, who experience accelerated biological aging even when their viral levels are controlled. A parallel study in HIV patients with fatty liver disease produced similar results, including indicators of improved physical function and chromosome protection. Researchers caution this doesn’t reverse aging but rather signals a potential slowdown in aging-related biological processes. Larger clinical trials are needed to confirm the findings and determine whether benefits extend beyond the HIV population, with plans to develop personalized “aging dashboards” that track individual biological aging patterns to guide targeted therapies.

Read the full article

Continue reading at Hacker News →

This is an AI-generated summary. Read the original for the full story.